Cargando…

Expression and Impact of C1GalT1 in Cancer Development and Progression

SIMPLE SUMMARY: C1GalT1 is one of the enzymes that catalyze the addition of sugar residues to proteins (protein glycosylation). It specifically controls the synthesis and formation of a special disaccharide structure Galβ1,3GalNAcα-, which occurs predominately in cancer but rarely in normal cells. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Yangu, Yu, Lu-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699795/
https://www.ncbi.nlm.nih.gov/pubmed/34944925
http://dx.doi.org/10.3390/cancers13246305
_version_ 1784620599653433344
author Wan, Yangu
Yu, Lu-Gang
author_facet Wan, Yangu
Yu, Lu-Gang
author_sort Wan, Yangu
collection PubMed
description SIMPLE SUMMARY: C1GalT1 is one of the enzymes that catalyze the addition of sugar residues to proteins (protein glycosylation). It specifically controls the synthesis and formation of a special disaccharide structure Galβ1,3GalNAcα-, which occurs predominately in cancer but rarely in normal cells. Recent studies have shown that C1GalT1 is overexpressed in many common cancers including colon, breast, gastric, lung, head and neck, pancreatic, esophageal, prostate, and hepatocellular cancer. C1GalT1 overexpression is also often associated with poorer prognosis and poorer patient survival. This review summarizes our current understanding of the expression of C1GalT1 in various cancers and discusses the impact of C1GalT change on cancer cell activities in cancer development and progression. ABSTRACT: C1GalT1 (T-synthase) is one of the key glycosyltransferases in the biosynthesis of O-linked mucin-type glycans of glycoproteins. It controls the formation of Core-1 disaccharide Galβ1,3GalNAcα- (Thomsen–Friedenreich oncofetal antigen, T or TF antigen) and Core-1-associated carbohydrate structures. Recent studies have shown that C1GalT1 is overexpressed in many cancers of epithelial origin including colon, breast, gastric, head and neck, pancreatic, esophageal, prostate, and hepatocellular cancer. Overexpression of C1GalT1 is often seen to also be associated with poorer prognosis and poorer patient survival. Change of C1GalT1 expression causes glycosylation changes of many cell membrane glycoproteins including mucin proteins, growth factor receptors, adhesion molecules, and death receptors. This leads to alteration of the interactions of these cell surface molecules with their binding ligands, resulting in changes of cancer cell activity and behaviors. This review summarizes our current understanding of the expression of C1GalT1 in various cancers and discusses the impact of C1GalT change on cancer cell activities in cancer development and progression.
format Online
Article
Text
id pubmed-8699795
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86997952021-12-24 Expression and Impact of C1GalT1 in Cancer Development and Progression Wan, Yangu Yu, Lu-Gang Cancers (Basel) Review SIMPLE SUMMARY: C1GalT1 is one of the enzymes that catalyze the addition of sugar residues to proteins (protein glycosylation). It specifically controls the synthesis and formation of a special disaccharide structure Galβ1,3GalNAcα-, which occurs predominately in cancer but rarely in normal cells. Recent studies have shown that C1GalT1 is overexpressed in many common cancers including colon, breast, gastric, lung, head and neck, pancreatic, esophageal, prostate, and hepatocellular cancer. C1GalT1 overexpression is also often associated with poorer prognosis and poorer patient survival. This review summarizes our current understanding of the expression of C1GalT1 in various cancers and discusses the impact of C1GalT change on cancer cell activities in cancer development and progression. ABSTRACT: C1GalT1 (T-synthase) is one of the key glycosyltransferases in the biosynthesis of O-linked mucin-type glycans of glycoproteins. It controls the formation of Core-1 disaccharide Galβ1,3GalNAcα- (Thomsen–Friedenreich oncofetal antigen, T or TF antigen) and Core-1-associated carbohydrate structures. Recent studies have shown that C1GalT1 is overexpressed in many cancers of epithelial origin including colon, breast, gastric, head and neck, pancreatic, esophageal, prostate, and hepatocellular cancer. Overexpression of C1GalT1 is often seen to also be associated with poorer prognosis and poorer patient survival. Change of C1GalT1 expression causes glycosylation changes of many cell membrane glycoproteins including mucin proteins, growth factor receptors, adhesion molecules, and death receptors. This leads to alteration of the interactions of these cell surface molecules with their binding ligands, resulting in changes of cancer cell activity and behaviors. This review summarizes our current understanding of the expression of C1GalT1 in various cancers and discusses the impact of C1GalT change on cancer cell activities in cancer development and progression. MDPI 2021-12-15 /pmc/articles/PMC8699795/ /pubmed/34944925 http://dx.doi.org/10.3390/cancers13246305 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Wan, Yangu
Yu, Lu-Gang
Expression and Impact of C1GalT1 in Cancer Development and Progression
title Expression and Impact of C1GalT1 in Cancer Development and Progression
title_full Expression and Impact of C1GalT1 in Cancer Development and Progression
title_fullStr Expression and Impact of C1GalT1 in Cancer Development and Progression
title_full_unstemmed Expression and Impact of C1GalT1 in Cancer Development and Progression
title_short Expression and Impact of C1GalT1 in Cancer Development and Progression
title_sort expression and impact of c1galt1 in cancer development and progression
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699795/
https://www.ncbi.nlm.nih.gov/pubmed/34944925
http://dx.doi.org/10.3390/cancers13246305
work_keys_str_mv AT wanyangu expressionandimpactofc1galt1incancerdevelopmentandprogression
AT yulugang expressionandimpactofc1galt1incancerdevelopmentandprogression